Vascular Risk Score and Associations With Past, Current, or Future Migraine in Women
Authors:
- Khatera IbrahimiKIKhatera Ibrahimi
- Pamela M. RistPRPamela M. Rist
- Claire CarpenetCCClaire Carpenet
- Jessica L. RohmannJRJessica L. Rohmann
- Julie E. BuringJBJulie E. Buring
- Antoinette Maassen van Den BrinkABAntoinette Maassen van Den Brink
- Tobias KurthTKTobias Kurth
- 18 October 2022
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 99 (16) , e1694-e1701
Abstract
Background and Objectives Migraine has consistently been associated with an increased risk of cardiovascular disease (CVD) events. It remains, however, unclear to what extent cardiovascular risk profiles might be linked with migraine activity status and how these profiles relate to the development of migraine. Methods We used data from a cohort study of female health professionals (Women9s Health Study, n = 27,539, age ≥45 years at baseline) without a history of CVD or other major diseases and who provided a blood sample at baseline. Framingham risk scores (FRSs) estimating the 10-year risk of coronary heart disease calculated at baseline were used to create vascular risk categories. The presence or development of self-reported migraine was assessed by questionnaires. Women were classified as having no migraine, history of migraine (experienced migraine in the past but did not experience any migraine attacks in the year before enrollment), active migraine at baseline (active), or incident migraine (first report of migraine during follow-up but not at baseline). We used multinomial logistic regression models to calculate ORs for the association between FRS categories and migraine status. Results Of the 27,539 participants, a total of 21,927 women did not report migraine, 1,500 women reported a history of migraine, 3,579 had migraine at baseline, and 533 reported migraine for the first time during follow-up. The odds of the probability of having a history of migraine at baseline (vs never migraine) was 76% higher among those with FRS ≥10% compared with FRS ≤1% after adjustment (OR = 1.76, 95% CI 1.39–2.23). In contrast, having FRS ≥10% was associated with reduced odds of having active migraine at baseline (OR = 0.64, 95% CI 0.52–0.80) and with newly reported migraine during follow-up (OR = 0.42, 95% CI 0.22–0.81) when compared with women with FRS category ≤1% and those not reporting migraine. A similar association pattern was observed for FRS categories 5%–9% and 2%–4%. Discussion High FRS categories were only observed among women with a history of migraine but not with active migraine at baseline or incident migraine after baseline. Our results suggest that the life course of migraine should be considered when studying associations with the vascular system. Our data further suggest that a relatively healthy vascular system, as assessed by the FRS, is associated with active migraine status or developing migraine in the future.Keywords
This publication has 49 references indexed in Scilit:
- Associations between lipid levels and migraine: Cross-sectional analysis in the Epidemiology of Vascular Ageing StudyCephalalgia, 2011
- Family history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population studyHeart, 2010
- Headache, migraine and cardiovascular risk factors: The HUNT studyEuropean Journal of Neurology, 2010
- Agreement of Self-Reported Migraine With ICHD-II Criteria in the Women's Health StudyCephalalgia, 2009
- Relation of familial patterns of coronary heart disease, stroke, and diabetes to subclinical atherosclerosis: the multi-ethnic study of atherosclerosisGenetics in Medicine, 2008
- Observational Studies Analyzed Like Randomized ExperimentsEpidemiology, 2008
- Relation of Framingham Risk Score to Subclinical Atherosclerosis Evaluated Across Three Arterial SitesThe American Journal of Cardiology, 2008
- Migraine, vascular risk, and cardiovascular events in women: prospective cohort studyBMJ, 2008
- Probable Migraine With Visual Aura and Risk of Ischemic StrokeStroke, 2007
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001